AAAAAA

   
Results: 1-25 | 26-50 | 51-75 | 76-100 | >>

Table of contents of journal: *Diabetes research and clinical practice (Print)

Results: 1-25/1187

Authors: Tang, Y Osawa, H Onuma, H Nishimiya, T Ochi, M Sugita, A Makino, H
Citation: Y. Tang et al., Phosphodiesterase 3B gene expression is enhanced in the liver but reduced in the adipose tissue of obese insulin resistant db/db mouse, DIABET RE C, 54(3), 2001, pp. 145-155

Authors: Darko, DA Dornhorst, A Kennedy, G Mandeno, RC Seed, M
Citation: Da. Darko et al., Glycaemic control and plasma lipoproteins in menopausal women with Type 2 diabetes treated with oral and transdermal combined hormone replacement therapy, DIABET RE C, 54(3), 2001, pp. 157-164

Authors: Tso, TK Snook, JT Lozano, RA Zipf, WB
Citation: Tk. Tso et al., Risk factors for coronary heart disease in type 1 diabetic children: the influence of apoE phenotype and glycemic regulation, DIABET RE C, 54(3), 2001, pp. 165-171

Authors: Suzuki, K Kato, K Hanyu, O Nakagawa, O Aizawa, Y
Citation: K. Suzuki et al., Left ventricular mass index increases in proportion to the progression of diabetic nephropathy in Type 2 diabetic patients, DIABET RE C, 54(3), 2001, pp. 173-180

Authors: Nakamura, T Funahashi, T Yamashita, S Nishida, M Nishida, Y Takahashi, M Hotta, K Kuriyama, H Kihara, S Ohuchi, N Nishimura, T Kishino, B Ishikawa, K Kawamoto, T Tokunaga, K Nakagawa, C Mineo, I Watanabe, F Tarui, S Matsuzawa, Y
Citation: T. Nakamura et al., Thiazolidinedione derivative improves fat distribution and multiple risk factors in subjects with visceral fat accumulation - double-blind placebo-controlled trial, DIABET RE C, 54(3), 2001, pp. 181-190

Authors: Baba, S
Citation: S. Baba, Nifedipine and enalapril equally reduce the progression of nephropathy in hypertensive type 2 diabetics, DIABET RE C, 54(3), 2001, pp. 191-201

Authors: Erem, C Yildiz, R Kavgaci, H Karahan, C Deger, O Can, G Telatar, M
Citation: C. Erem et al., Prevalence of diabetes, obesity and hypertension in a Turkish population (Trabzon city), DIABET RE C, 54(3), 2001, pp. 203-208

Authors: Tokuyama, Y Nozaki, O Kanatsuka, A
Citation: Y. Tokuyama et al., A patient with subcutaneous-insulin resistance treated by insulin lispro plus heparin, DIABET RE C, 54(3), 2001, pp. 209-212

Authors: Dzien, A Dzien-Bischinger, C Hoppichler, F Lechleitner, M
Citation: A. Dzien et al., Fasting glucose concentrations and cardiovasular disease; are the new diagnostic criteria not strict enough?, DIABET RE C, 54(3), 2001, pp. 213-214

Authors: Iwase, M Gotoh, D Urata, M Kang, D Hamasaki, N Yoshinari, M Fujishima, M
Citation: M. Iwase et al., Clinical features of diabetic patients with 0.01-0.1% heteroplasmy A3243G mutation in leukocyte mitochondrial DNA, DIABET RE C, 54(3), 2001, pp. 215-217

Authors: Franzese, A Iorio, R Buono, P Mascolo, M Mozzillo, E Valerio, G
Citation: A. Franzese et al., Mauriac syndrome still exists, DIABET RE C, 54(3), 2001, pp. 219-221

Authors: Palin, SL
Citation: Sl. Palin, HRT in women with diabetes - review of the effects on glucose and lipid metabolism, DIABET RE C, 54(2), 2001, pp. 67-77

Authors: Sano, R Miki, T Suzuki, Y Shimada, F Taira, M Kanatsuka, A Makino, H Hashimoto, N Saito, Y
Citation: R. Sano et al., Analysis of the insulin-sensitive phosphodiesterase 3B gene in type 2 diabetes, DIABET RE C, 54(2), 2001, pp. 79-88

Authors: Kumaramanickavel, A Sripriya, S Vellanki, RN Upadyay, NK Badrinath, SS Arokiasamy, T Sukumar, B Vidha, A Joseph, B Sharma, T Gopal, L
Citation: A. Kumaramanickavel et al., Tumor necrosis factor allelic polymorphism with diabetic retinopathy in India, DIABET RE C, 54(2), 2001, pp. 89-94

Authors: Araz, M Yilmaz, N Gungor, K Okan, V Kepekci, Y Aynacioglu, AS
Citation: M. Araz et al., Angiotensin-converting enzyme gene polymorphism and microvascular complications in Turkish type 2 diabetic patients, DIABET RE C, 54(2), 2001, pp. 95-104

Authors: Tamas, G Marre, M Astorga, R Dedov, I Jacobsen, J Lindholm, A
Citation: G. Tamas et al., Glycaemic control in type I diabetic patients using optimised insulin aspart or human insulin in a randomised multinational study, DIABET RE C, 54(2), 2001, pp. 105-114

Authors: Olaleye, D Perkins, BA Bril, V
Citation: D. Olaleye et al., Evaluation of three screening tests and a risk assessment model for diagnosing peripheral neuropathy in the diabetes clinic, DIABET RE C, 54(2), 2001, pp. 115-128

Authors: Migdalis, IN Kalogeropoulou, B Iliopoulou, V Triantafilou, P Charalabides, J Mortzos, G Cordopatis, C
Citation: In. Migdalis et al., Plasma levels of endothelin, lipid peroxides and prostacyclin in diabetic patients with macroangiopathy, DIABET RE C, 54(2), 2001, pp. 129-136

Authors: Ishii, C Inoue, K Negishi, K Tane, N Awata, T Katayama, S
Citation: C. Ishii et al., Diabetic ketoacidosis in a case of pheochromocytoma, DIABET RE C, 54(2), 2001, pp. 137-142

Authors: Taniguchi, T Okamoto, M Ueno, H Tanaka, J Okamoto, M Hamasaki, A Yamada, Y Seino, Y
Citation: T. Taniguchi et al., Use of the insulin sensitivity index obtained from oral glucose tolerance test in Japanese subjects, DIABET RE C, 54(2), 2001, pp. 143-144

Authors: Reddy, G Stehno-Bittel, L Hamade, S Enwemeka, CS
Citation: G. Reddy et al., The biomechanical integrity of bone in experimental diabetes, DIABET RE C, 54(1), 2001, pp. 1-8

Authors: Hirose, T Miyashita, Y Takagi, M Sumitani, S Kouhara, H Kasayama, S
Citation: T. Hirose et al., Characteristics of type 2 diabetic patients responding to voglibose administration as an adjunct to sulfonylurea, DIABET RE C, 54(1), 2001, pp. 9-15

Authors: Cox, DJ Gonder-Frederick, LA Kovatchev, BP Clarke, WL
Citation: Dj. Cox et al., Self-treatment of hypoglycemia while driving, DIABET RE C, 54(1), 2001, pp. 17-26

Authors: Chen, BH Chung, SB Chiang, W Chao, MC
Citation: Bh. Chen et al., GAD65 antibody prevalence and association with thyroid antibodies, HLA-DR in Chinese children with type I diabetes mellitus, DIABET RE C, 54(1), 2001, pp. 27-32

Authors: Vanizor, B Orem, A Karahan, SC Kiran, E Erem, C Aliyazicioglu, R Uydu, HA
Citation: B. Vanizor et al., Decreased nitric oxide end-products and its relationship with high densitylipoprotein and oxidative stress in people with type 2 diabetes without complications, DIABET RE C, 54(1), 2001, pp. 33-39
Risultati: 1-25 | 26-50 | 51-75 | 76-100 | >>